PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 178 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2018. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $296,000 | +24.9% | 5,000 | +108.3% | 0.00% | – |
| Q4 2017 | $237,000 | -69.5% | 2,400 | -63.1% | 0.00% | -100.0% |
| Q3 2017 | $778,000 | -48.2% | 6,500 | -62.2% | 0.00% | -50.0% |
| Q2 2017 | $1,503,000 | -89.9% | 17,200 | -72.7% | 0.00% | -87.5% |
| Q1 2015 | $14,875,000 | +24.6% | 63,000 | -0.1% | 0.02% | +33.3% |
| Q4 2014 | $11,936,000 | -24.9% | 63,064 | -5.4% | 0.01% | -25.0% |
| Q3 2014 | $15,904,000 | – | 66,664 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
| Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
| Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
| Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
| GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
| Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
| Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
| ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |